Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionglucuronosyltransferase activity

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CHPF2 UGT2B28

3.47e-08351106GO:0015020
GeneOntologyMolecularFunctionretinoic acid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1

4.11e-07281105GO:0001972
GeneOntologyMolecularFunctionretinoid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1

6.56e-06481105GO:0005501
GeneOntologyMolecularFunctionisoprenoid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1

7.28e-06491105GO:0019840
GeneOntologyMolecularFunctionUDP-glycosyltransferase activity

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CHPF2 WDFY3 UGT2B28

2.22e-051531107GO:0008194
GeneOntologyMolecularFunctionprotein kinase C binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9 LDB3

3.17e-05661105GO:0005080
GeneOntologyMolecularFunctionsteroid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9 RORA VDAC2

9.47e-051331106GO:0005496
GeneOntologyMolecularFunctionhexosyltransferase activity

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CHPF2 WDFY3 UGT2B28

1.69e-042111107GO:0016758
GeneOntologyMolecularFunctionmonocarboxylic acid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1

3.15e-041071105GO:0033293
GeneOntologyMolecularFunctionfatty acid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.72e-04691104GO:0005504
GeneOntologyMolecularFunctionglycosyltransferase activity

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CHPF2 WDFY3 UGT2B28

1.08e-032881107GO:0016757
GeneOntologyBiologicalProcessestrogen catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.81e-0951104GO:0006711
GeneOntologyBiologicalProcessphenylpropanoid catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.14e-0861104GO:0046271
GeneOntologyBiologicalProcesscoumarin catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.14e-0861104GO:0046226
GeneOntologyBiologicalProcessflavone metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.14e-0861104GO:0051552
GeneOntologyBiologicalProcesscellular glucuronidation

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

7.48e-08211105GO:0052695
GeneOntologyBiologicalProcessphenylpropanoid metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.57e-07101104GO:0009698
GeneOntologyBiologicalProcesscoumarin metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.57e-07101104GO:0009804
GeneOntologyBiologicalProcessglucuronate metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.37e-07261105GO:0019585
GeneOntologyBiologicalProcessuronic acid metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.37e-07261105GO:0006063
GeneOntologyBiologicalProcessxenobiotic glucuronidation

UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.67e-07121104GO:0052697
GeneOntologyBiologicalProcessflavonoid metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.28e-07131104GO:0009812
GeneOntologyBiologicalProcessflavonoid glucuronidation

UGT1A8 UGT1A7 UGT1A9

1.46e-0651103GO:0052696
GeneOntologyBiologicalProcesshormone catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.27e-06211104GO:0042447
GeneOntologyBiologicalProcessestrogen metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

8.38e-06521105GO:0008210
GeneOntologyBiologicalProcessxenobiotic metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1 RORA UGT2B28

1.06e-051411107GO:0006805
GeneOntologyBiologicalProcesshormone metabolic process

PLB1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1 ASMT UGT2B28 GNB3

2.28e-052861109GO:0042445
GeneOntologyBiologicalProcesssecondary metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1

2.92e-05671105GO:0019748
GeneOntologyBiologicalProcesssteroid catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.14e-05341104GO:0006706
GeneOntologyBiologicalProcessretinoic acid metabolic process

UGT1A8 UGT1A7 UGT1A9 CYP2W1

6.04e-05401104GO:0042573
GeneOntologyBiologicalProcessretinoid metabolic process

PLB1 UGT1A8 UGT1A7 UGT1A9 CYP2W1

1.14e-04891105GO:0001523
GeneOntologyBiologicalProcessditerpenoid metabolic process

PLB1 UGT1A8 UGT1A7 UGT1A9 CYP2W1

1.48e-04941105GO:0016101
GeneOntologyBiologicalProcessregulation of phospholipid efflux

ABCA3 ABCA7

1.68e-0441102GO:1902994
GeneOntologyBiologicalProcesspositive regulation of phospholipid efflux

ABCA3 ABCA7

1.68e-0441102GO:1902995
GeneOntologyBiologicalProcesssteroid metabolic process

LMF1 UGT1A10 UGT1A8 UGT1A7 SREBF1 UGT1A9 RORA UGT2B28 GNB3

1.86e-043761109GO:0008202
GeneOntologyBiologicalProcesscellular response to xenobiotic stimulus

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CYP2W1 RORA UGT2B28

1.89e-042221107GO:0071466
GeneOntologyBiologicalProcessterpenoid metabolic process

PLB1 UGT1A8 UGT1A7 UGT1A9 CYP2W1

2.49e-041051105GO:0006721
GeneOntologyBiologicalProcesspositive regulation of protein ubiquitination

MYCBP2 TICAM1 FANCM PAXIP1 ARRDC3

5.36e-041241105GO:0031398
GeneOntologyBiologicalProcessGDP-mannose biosynthetic process

GMPPB GMPPA

5.82e-0471102GO:0009298
GeneOntologyBiologicalProcessmyeloid dendritic cell cytokine production

TICAM1 MAVS

5.82e-0471102GO:0002372
GeneOntologyBiologicalProcessregulation of myeloid dendritic cell cytokine production

TICAM1 MAVS

5.82e-0471102GO:0002733
GeneOntologyBiologicalProcesspositive regulation of myeloid dendritic cell cytokine production

TICAM1 MAVS

5.82e-0471102GO:0002735
DomainUDPGT

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.34e-07211125PF00201
DomainUDPGT

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.34e-07211125PS00375
DomainUDP_glucos_trans

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.34e-07211125IPR002213
DomainHEXAPEP_TRANSFERASES

GMPPB GMPPA

3.56e-0521122PS00101
DomainHexapep_transf_CS

GMPPB GMPPA

3.56e-0521122IPR018357
DomainABC_A

ABCA3 ABCA7 ABCA6

4.44e-05121123IPR026082
DomainNTP_transferase

GMPPB GMPPA

1.07e-0431122PF00483
DomainNTP_transferase_dom

GMPPB GMPPA

1.07e-0431122IPR005835
DomainHexapep

GMPPB GMPPA

3.52e-0451122IPR001451
DomainHexapep

GMPPB GMPPA

3.52e-0451122PF00132
DomainMab-21-like_1/2

MAB21L2 MAB21L1

3.52e-0451122IPR020950
DomainHelicase/UvrB_N

RTEL1 FANCM

9.75e-0481122IPR006935
DomainResIII

RTEL1 FANCM

9.75e-0481122PF04851
DomainPapD-like

CFAP65 HYDIN

1.25e-0391122IPR008962
Domaincalpain_III

CAPN9 CAPN10

2.26e-03121122SM00720
DomainC2_III

CAPN9 CAPN10

2.26e-03121122IPR033883
DomainMab-21

MAB21L2 MAB21L1

2.26e-03121122PF03281
DomainMab-21

MAB21L2 MAB21L1

2.26e-03121122SM01265
DomainCalpain_III

CAPN9 CAPN10

2.26e-03121122IPR022683
DomainMab-21_dom

MAB21L2 MAB21L1

2.26e-03121122IPR024810
DomainLink_dom

STAB1 TNFAIP6

2.66e-03131122IPR000538
DomainXlink

STAB1 TNFAIP6

2.66e-03131122PF00193
DomainLINK_2

STAB1 TNFAIP6

2.66e-03131122PS50963
DomainCalpain_III

CAPN9 CAPN10

2.66e-03131122PF01067
DomainLINK

STAB1 TNFAIP6

2.66e-03131122SM00445
DomainCalpain_domain_III

CAPN9 CAPN10

2.66e-03131122IPR022682
DomainLINK_1

STAB1 TNFAIP6

2.66e-03131122PS01241
DomainABC_tran

ABCA3 ABCA7 ABCA6

2.98e-03481123PF00005
DomainABC_TRANSPORTER_2

ABCA3 ABCA7 ABCA6

2.98e-03481123PS50893
DomainCalpain_cysteine_protease

CAPN9 CAPN10

3.09e-03141122IPR022684
DomainABC_TRANSPORTER_1

ABCA3 ABCA7 ABCA6

3.16e-03491123PS00211
DomainABC_transporter-like

ABCA3 ABCA7 ABCA6

3.35e-03501123IPR003439
DomainPeptidase_C2

CAPN9 CAPN10

3.56e-03151122PF00648
DomainCysPc

CAPN9 CAPN10

3.56e-03151122SM00230
DomainPeptidase_C2_calpain_cat

CAPN9 CAPN10

3.56e-03151122IPR001300
DomainCALPAIN_CAT

CAPN9 CAPN10

3.56e-03151122PS50203
Domain-

ABCA3 RTEL1 DDX60 MYO18A PEX6 CMPK2 FANCM ABCA7 DNAH14 ABCA6 HYDIN

5.18e-03746112113.40.50.300
PathwayREACTOME_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.44e-0724835MM14599
PathwayREACTOME_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.03e-0725835M17787
PathwayWP_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.03e-0725835MM15820
PathwayKEGG_ASCORBATE_AND_ALDARATE_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.03e-0725835M605
PathwayWP_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.74e-0726835M39404
PathwayKEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

5.53e-0728835M19580
PathwayREACTOME_PARACETAMOL_ADME

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.08e-0639835MM15695
PathwayKEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.97e-0641835M7399
PathwayREACTOME_ASPIRIN_ADME

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

6.36e-0645835MM15694
PathwayWP_ESTROGEN_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.54e-0622834MM15888
PathwayKEGG_DRUG_METABOLISM_OTHER_ENZYMES

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.19e-0551835M17726
PathwayKEGG_STARCH_AND_SUCROSE_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.31e-0552835M14171
PathwayKEGG_STEROID_HORMONE_BIOSYNTHESIS

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.73e-0555835M14933
PathwayKEGG_RETINOL_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.64e-0564835M9488
PathwayKEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

5.62e-0570835M16794
PathwayKEGG_DRUG_METABOLISM_CYTOCHROME_P450

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

6.43e-0572835M9257
PathwayWP_CODEINE_AND_MORPHINE_METABOLISM

UGT1A10 UGT1A8 UGT1A9

6.84e-0514833M39328
PathwayREACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS

ABCA3 ABCA7 ABCA6

1.26e-0417833MM14552
PathwayREACTOME_ASPIRIN_ADME

UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.27e-0444834M45014
PathwayREACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS

ABCA3 ABCA7 ABCA6

1.51e-0418833M524
PathwayREACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

4.16e-04107835MM14595
PathwayREACTOME_DRUG_ADME

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

4.53e-04109835M45012
PathwayREACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

4.53e-04109835M18788
PathwayREACTOME_SYNTHESIS_OF_GDP_MANNOSE

GMPPB GMPPA

5.06e-046832MM17218
PathwayREACTOME_SYNTHESIS_OF_GDP_MANNOSE

GMPPB GMPPA

5.06e-046832M27374
PathwayREACTOME_DRUG_ADME

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

6.77e-04119835MM15692
PathwayWP_WHITE_FAT_CELL_DIFFERENTIATION

SREBF1 RORA CTNNA1

8.63e-0432833M39333
PathwayWP_WHITE_FAT_CELL_DIFFERENTIATION

SREBF1 RORA CTNNA1

9.45e-0433833MM15869
PathwayKEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL

GMPPB GMPPA

1.20e-039832M47613
PathwayWP_2Q37_COPY_NUMBER_VARIATION_SYNDROME

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CAPN10

1.64e-03145835M45512
Pubmed

Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-096112432527940
Pubmed

Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-096112420297805
Pubmed

Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.54e-09711248467709
Pubmed

Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.54e-09711248464825
Pubmed

Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.54e-097112427514509
Pubmed

Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.06e-098112417179145
Pubmed

Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.06e-098112420610558
Pubmed

Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.06e-098112418052087
Pubmed

A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-089112422511988
Pubmed

Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.11e-0810112423642732
Pubmed

UDP-glucuronosyltransferases.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.11e-0810112411465080
Pubmed

A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.11e-0810112423371916
Pubmed

A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.11e-0810112422558097
Pubmed

Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α Is Mediated by a Novel Composite Regulatory Element.

UGT1A10 UGT1A8 UGT1A9

3.25e-083112329519853
Pubmed

Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.

UGT1A10 UGT1A8 UGT1A9

3.25e-083112312847094
Pubmed

Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.94e-0812112420308471
Pubmed

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.94e-0812112419419973
Pubmed

Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.94e-0812112411434514
Pubmed

UGT1A1 is a major locus influencing bilirubin levels in African Americans.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.12e-0813112422085899
Pubmed

Genome-wide analysis of hepatic lipid content in extreme obesity.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.12e-0813112425246029
Pubmed

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

UGT1A10 UGT1A8 UGT1A7 UGT1A9 SGO2 UGT2B28

7.56e-0866112619898482
Pubmed

Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.95e-0814112421646302
Pubmed

Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.95e-0814112410836148
Pubmed

Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.95e-0814112414672974
Pubmed

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.95e-081411249295054
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

PSD CENPB ARHGAP10 ZNF212 PEX6 ABCA7 SLC4A1 LRIG3 ZNF469 CHPF2 BICRAL WDFY3 TSR3 ANKRD52 TLCD3A PDZRN3 NIN

1.10e-0711161121731753913
Pubmed

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28.

UGT1A10 UGT1A7 UGT1A9

1.30e-074112317558305
Pubmed

Genome-wide association meta-analysis for total serum bilirubin levels.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.80e-0716112419414484
Pubmed

Genome-wide association of serum bilirubin levels in Korean population.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.35e-0717112420639394
Pubmed

Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.01e-0718112420056724
Pubmed

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

UGT1A8 UGT1A7 UGT1A9

3.24e-075112320565459
Pubmed

Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.

UGT1A10 UGT1A8 UGT1A9

3.24e-075112315057901
Pubmed

A genome-wide assessment of variability in human serum metabolism.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.80e-0719112423281178
Pubmed

An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan.

MAB21L2 DCLK2 MAB21L1

6.46e-076112319482073
Pubmed

Genetic determinants influencing human serum metabolome among African Americans.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.03e-0624112424625756
Pubmed

Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.

UGT1A10 UGT1A8 UGT1A9

2.69e-069112320732626
Pubmed

Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.

UGT1A8 UGT1A7 UGT1A9

5.26e-0611112318695635
Pubmed

CD40 Mediates Maturation of Thymic Dendritic Cells Driven by Self-Reactive CD4+ Thymocytes and Supports Development of Natural Regulatory T Cells.

RAG2 TICAM1 MAVS

9.08e-0613112329321275
Pubmed

Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.

ESRP1 ESRP2

1.03e-052112225143390
Pubmed

The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.

ESRP1 ESRP2

1.03e-052112219829082
Pubmed

Dual Roles for Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) in Cancer Progression.

ESRP1 ESRP2

1.03e-052112227401076
Pubmed

Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis.

SREBF1 CHI3L1

1.03e-052112230935969
Pubmed

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.

UGT1A10 UGT1A9

1.03e-052112225547628
Pubmed

Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing.

ESRP1 ESRP2

1.03e-052112222354987
Pubmed

The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development.

MAB21L2 MAB21L1

1.03e-052112227558071
Pubmed

Cloning, expression and characterization of the pig liver GDP-mannose pyrophosphorylase. Evidence that GDP-mannose and GDP-Glc pyrophosphorylases are different proteins.

GMPPB GMPPA

1.03e-052112211082198
Pubmed

Coupling of ryanodine receptor 2 and voltage-dependent anion channel 2 is essential for Ca²+ transfer from the sarcoplasmic reticulum to the mitochondria in the heart.

RYR2 VDAC2

1.03e-052112222867515
Pubmed

An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition.

ESRP1 ESRP2

1.03e-052112220711167
Pubmed

A MAVS/TICAM-1-independent interferon-inducing pathway contributes to regulation of hepatitis B virus replication in the mouse hydrodynamic injection model.

TICAM1 MAVS

1.03e-052112225115498
Pubmed

Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection.

TICAM1 MAVS

1.03e-052112235108347
Pubmed

Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.

UGT1A10 UGT1A8

1.03e-052112211901093
Pubmed

Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.

ESRP1 ESRP2

1.03e-052112237090731
Pubmed

Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.

UGT1A7 UGT1A9

1.03e-052112211677206
Pubmed

DDX60 Is Involved in RIG-I-Dependent and Independent Antiviral Responses, and Its Function Is Attenuated by Virus-Induced EGFR Activation.

DDX60 MAVS

1.03e-052112225981042
Pubmed

Genomic cloning and chromosomal localization of the mouse Mab21l2 locus.

MAB21L2 MAB21L1

1.03e-052112210516425
Pubmed

Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.

UGT1A10 UGT1A9

1.03e-052112222031623
Pubmed

The global Protein-RNA interaction map of ESRP1 defines a post-transcriptional program that is essential for epithelial cell function.

ESRP1 ESRP2

1.03e-052112236238894
Pubmed

Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.

UGT1A10 UGT1A8

1.03e-052112210497143
Pubmed

Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.

UGT1A8 UGT1A9

1.03e-052112218568343
Pubmed

Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.

UGT1A10 UGT1A8

1.03e-052112217603215
Pubmed

UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.

UGT1A7 UGT1A9

1.03e-052112215709193
Pubmed

Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.

UGT1A7 UGT1A9

1.03e-052112212944498
Pubmed

Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.

ESRP1 ESRP2

1.03e-052112233339518
Pubmed

Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF.

TICAM1 MAVS

1.03e-052112222870331
Pubmed

Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.

TICAM1 MAVS

1.03e-052112224192491
Pubmed

Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart.

SREBF1 UCP3

1.03e-052112226555260
Pubmed

Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.

UGT1A10 UGT1A8

1.03e-05211229647757
Pubmed

Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

UGT1A7 UGT1A9

1.03e-052112217529886
Pubmed

Depletion of Mab21l1 and Mab21l2 messages in mouse embryo arrests axial turning, and impairs notochord and neural tube differentiation.

MAB21L2 MAB21L1

1.03e-052112211857508
Pubmed

The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases.

TICAM1 MAVS

1.03e-052112218756281
Pubmed

Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses.

TICAM1 MAVS

1.03e-052112218178804
Pubmed

Cryo-EM structures of human GMPPA-GMPPB complex reveal how cells maintain GDP-mannose homeostasis.

GMPPB GMPPA

1.03e-052112233986552
Pubmed

How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?

UGT1A10 UGT1A9

1.03e-052112220089735
Pubmed

Ablation of the epithelial-specific splicing factor Esrp1 results in ureteric branching defects and reduced nephron number.

ESRP1 ESRP2

1.03e-052112227404344
Pubmed

Microglia are involved in phagocytosis and extracellular digestion during Zika virus encephalitis in young adult immunodeficient mice.

TICAM1 MAVS

1.03e-052112234399779
Pubmed

IL-13 suppresses double-stranded RNA-induced IFN-λ production in lung cells.

TICAM1 MAVS

3.08e-053112221184733
Pubmed

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

UGT1A7 UGT1A9

3.08e-053112219364970
Pubmed

Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells.

TICAM1 MAVS

3.08e-053112227141827
Pubmed

Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.

TICAM1 MAVS

3.08e-053112228566380
Pubmed

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.

UGT1A7 UGT1A9

3.08e-053112216636344
Pubmed

Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.

UGT1A10 UGT1A9

3.08e-053112220007669
Pubmed

Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1α and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.

UGT1A8 UGT1A9

3.08e-053112223721685
Pubmed

Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.

UGT1A10 UGT1A8

3.08e-053112219244109
Pubmed

Immune Sensing of Aeroallergen-Associated Double-Stranded RNA Triggers an IFN Response and Modulates Type 2 Lung Inflammation.

TICAM1 MAVS

3.08e-053112231562213
Pubmed

Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9.

UGT1A8 UGT1A9

3.08e-053112226247833
Pubmed

Mouse superkiller-2-like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses.

DDX60 MAVS

3.08e-053112226457795
Pubmed

Down regulation of TRIF, TLR3, and MAVS in HCV infected liver correlates with the outcome of infection.

TICAM1 MAVS

3.08e-053112228480979
Pubmed

Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness.

TICAM1 MAVS

3.08e-053112232730309
Pubmed

The DNA damage- and transcription-associated protein paxip1 controls thymocyte development and emigration.

RAG2 PAXIP1

3.08e-053112223159437
Pubmed

The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.

UGT1A8 UGT1A9

3.08e-053112217339869
Pubmed

Competition for specific intrathymic ligands limits positive selection in a TCR transgenic model of CD4+ T cell development.

RAG2 HLA-DMA

3.08e-053112210843678
Pubmed

Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations.

UGT1A7 UGT1A9

3.08e-053112224453052
Pubmed

UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.

UGT1A8 UGT1A9

3.08e-053112219225446
Pubmed

The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.

ESRP1 ESRP2

3.08e-053112226522722
Pubmed

[Influence of genetic polymorphisms in UGT1A1, UGT1A7 and UGT1A9 on the pharmacokynetics of irinotecan, SN-38 and SN-38G].

UGT1A7 UGT1A9

3.08e-053112223789755
Pubmed

RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets.

RYR2 CAPN10

3.08e-053112215044459
Pubmed

Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer.

UGT1A7 UGT1A9

3.08e-053112217406868
Pubmed

Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

RAG2 TICAM1

3.08e-053112224990882
Pubmed

Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.

UGT1A8 UGT1A7

3.08e-053112219996319
Pubmed

Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.

UGT1A8 UGT1A9

3.08e-053112216397224
Cytoband2q37

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.00e-063111242q37
CytobandEnsembl 112 genes in cytogenetic band chr2q37

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CAPN10

2.42e-042261125chr2q37
GeneFamilyUDP glucuronosyltransferases

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.57e-0732795363
GeneFamilyATP binding cassette subfamily A

ABCA3 ABCA7 ABCA6

2.82e-0514793805
GeneFamilyC2 domain containing|Calpains

CAPN9 CAPN10

1.91e-0315792975
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

ARHGAP10 LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

4.80e-071871127bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCellControl-Fibroblasts|Control / group, cell type (main and fine annotations)

ARHGAP10 LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

5.34e-0719011273a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMA4 RYR2 MAMDC2 RORA REPS2 PDZRN3 SHISA3

5.54e-071911127fa380a8752de158974b2ae5e741573439719cc0d
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

RGCC LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

6.36e-07195112761c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

RGCC LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

6.36e-071951127aa0add081881d349099d12efca5cdee098038d4e
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP10 LAMA4 RYR2 FRY LDB3 DCLK2 PDZRN3

6.81e-071971127bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP10 LAMA4 RYR2 LDB3 ADAMTS6 DCLK2 PDZRN3

7.05e-071981127c12e7511628db819a52959bb68580e27c00c2e41
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor

LAMA4 LDB3 ADAMTS6 ASMT DCLK2 PDZRN3

3.23e-061601126d783d29150033e9181c0e30870070268fed3fd85
ToppCelldroplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ROBO4 LAMA4 PHETA2 SPRED3 STAB1 ANKRD52

6.56e-061811126fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCellwk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

PRSS3 APC2 MAB21L2 FRY DCLK2 MAB21L1

7.20e-061841126eac2a9089913f33a961ba11519b53645790f2056
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

RYR2 LRIG3 SEMA6D ADAMTS6 GPR153 RORA

7.66e-0618611267def03dd856b765bd3f493288641981c4f7fd26e
ToppCellCOVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations)

RYR2 FRY LDB3 RORA DCLK2 PDZRN3

7.90e-061871126464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

7.90e-06187112692d468dde81125d51daf7abd4703741abe1ab91c
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

LMF1 ARHGAP10 LENG8 SIK2 RORA REPS2

8.39e-061891126a48df46274d51e84ffb40264646de7346104efb9
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

LAMA4 RYR2 MAMDC2 RORA REPS2 SHISA3

8.65e-0619011267986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

8.91e-0619111266688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

9.18e-06192112699ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellTracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP10 ADAM21 LAMA4 ABCA6 PDZRN3 MAB21L1

9.46e-061931126549a0b750c860b615aff767ad04c9a9d20f802f0
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

9.46e-06193112699525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

9.46e-061931126b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

9.74e-061941126e93de9428c986b8943fc169258847c650cfab0e5
ToppCellControl-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations)

LAMA4 RYR2 ABCA6 RORA DCLK2 PDZRN3

9.74e-06194112603a269f75a481ea54aea8e6444605db8d6df493d
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMA4 ABCA6 MAMDC2 REPS2 PDZRN3 SHISA3

9.74e-0619411265f5f0cdeacd5e1b28717d78dabdb9eb95f661e36
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

LAMA4 ABCA6 MAMDC2 RORA PDZRN3 SHISA3

9.74e-06194112671d3c7448b1734de54187f902f65649f9283bd4c
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

TEX15 ABCA6 RORA REPS2 PDZRN3 SHISA3

9.74e-06194112699577a5a631e607b5abe7a1b0d8d6a5eabe50196
ToppCellCOVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type

ARHGAP10 RYR2 FRY LDB3 SEMA6D PDZRN3

9.74e-0619411265e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TEX15 ABCA6 RORA REPS2 PDZRN3 SHISA3

1.00e-05195112670387a62f121f8c374dba1aca9ab65cfed6a0b10
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

1.00e-051951126603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LAMA4 RYR2 ABCA6 MAMDC2 PDZRN3 SHISA3

1.03e-0519611269737a5f006d37b549f281e1863aca558e1e4dc99
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

1.03e-051961126bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LAMA4 RYR2 ABCA6 MAMDC2 PDZRN3 SHISA3

1.03e-051961126cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

1.03e-0519611267d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LAMA4 RYR2 LDB3 ADAMTS6 DCLK2 PDZRN3

1.06e-051971126ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP10 LAMA4 RYR2 ABCA6 MAMDC2 PDZRN3

1.06e-0519711266d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCellAdult-Mesenchymal|Adult / Lineage, Cell type, age group and donor

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

1.09e-05198112626e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

1.09e-051981126df3de77216f5c5d6141ec44d01c56b942f611838
ToppCelldistal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

LAMA4 RYR2 ABCA6 MAMDC2 TNFAIP6 PDZRN3

1.09e-0519811266594c35ab203dc51462167c61807b0d49fa30fb2
ToppCellnucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LAMA4 RYR2 ABCA6 MAMDC2 RORA PDZRN3

1.09e-0519811268f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LAMA4 RYR2 LDB3 ADAMTS6 DCLK2 PDZRN3

1.09e-05198112622e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

MYCBP2 LAMA4 CHI3L1 ABCA6 TNFAIP6 PDZRN3

1.13e-051991126fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYCBP2 LAMA4 CHI3L1 RYR2 ABCA6 PDZRN3

1.13e-051991126a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RGCC LAMA4 RYR2 ABCA6 MAMDC2 PDZRN3

1.16e-052001126e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellParenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LAMA4 RYR2 ABCA6 MAMDC2 TNFAIP6 PDZRN3

1.16e-0520011268c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LAMA4 RYR2 FRY LDB3 DCLK2 PDZRN3

1.16e-052001126a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

MYCBP2 LAMA4 CHI3L1 RYR2 ABCA6 PDZRN3

1.16e-052001126a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RGCC LAMA4 RYR2 ABCA6 MAMDC2 PDZRN3

1.16e-05200112634f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCellTCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-5|TCGA-Adrenal / Sample_Type by Project: Shred V9

PSD MAB21L2 CFAP65 GNB3 PLXNB1

2.26e-051341125d4b175257c47916ed90cdb5c555c2b26530ce8d5
ToppCellChildren_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor

VTN ABCA6 MAMDC2 RORA PDZRN3

4.82e-051571125f147e24f2ece82e1c54750868954d09b3c461804
ToppCellChildren_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

VTN ABCA6 MAMDC2 RORA PDZRN3

4.97e-051581125e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCellAdult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor

LAMA4 RYR2 ABCA6 MAMDC2 PDZRN3

5.12e-0515911253f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

RGCC RYR2 MAMDC2 REPS2 SHISA3

5.27e-0516011250293b244c063a62819690bf22bbc2681f8d15252
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

RGCC RYR2 MAMDC2 REPS2 SHISA3

5.27e-0516011253eaae86fa08f7651021316f8e5811bf48055591e
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-CR|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TEX15 LRIG3 HYDIN MAB21L1

5.75e-058311241ab68323518adc7fd0a459b41fad12d60f97eb5c
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-CR-CR_Lhx5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

TEX15 LRIG3 HYDIN MAB21L1

5.75e-0583112475b27d91a4473286f4b40027e96ac5246f5abe5b
ToppCellEndothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

CAPN9 ROBO4 LAMA4 RYR2 DLK2

6.46e-0516711256a03d16165e0b003092c39972928981abd4a75aa
ToppCellPND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ROBO4 MTMR11 MAVS ARRDC3 TLCD3A

6.65e-051681125c7021748003e5949f7caf7b3291c5bad294948c1
ToppCellfacs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA4 ABCA6 RORA TNFAIP6 DSCC1

6.83e-051691125849a8f8509c58d65462a09c84d58b6ecdc8934f5
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

LAMA4 FANCM MAMDC2 SGO2 TIMM29

7.23e-051711125b113fbebb89056af0b9c775d2fb6552206a80467
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor

RYR2 LDB3 MTMR11 DCLK2 PDZRN3

7.63e-051731125a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LAMA4 RYR2 LDB3 DCLK2 PDZRN3

7.63e-051731125cb6389536195443633adb06e5f1b7483530773d1
ToppCellPND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass

ROBO4 STAB1 CFAP65 ZBTB45 SEMA6D

7.84e-051741125b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular|TCGA-Thryoid / Sample_Type by Project: Shred V9

ROBO4 RTN4IP1 ARHGAP22 FAM167A DCLK2

8.06e-05175112549211b260bbe3c88354fbd1953dc06f92d3eab09
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VTN CENPL ARHGAP10 LAMA4 STAB1

8.06e-0517511250801cccec6915aefc135262fc74580280fd51aa5
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VTN CENPL ARHGAP10 LAMA4 STAB1

8.06e-05175112509163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ABCA3 ZNF469 DSCC1 HYDIN

8.23e-05911124b0658e020f80e56fab9d2aa07e321d9b33d7af2c
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PHETA2 ZBTB45 PAXIP1 SIK2 SLC38A7

8.28e-0517611251510cdfcfb46ce1196a1220c07fb5f3986c81b78
ToppCell356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells)

LAMA4 RYR2 MAMDC2 PDZRN3 SHISA3

8.50e-0517711258220cc2fc0ee8764a67a3be51d75248be2453040
ToppCellNS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

RTN4IP1 MAMDC2 OGDHL DCLK2 PDZRN3

8.50e-05177112599500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCellPND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ABCA3 ESRP1 TEX15 CHI3L1 SGO2

8.50e-051771125a68c3688f12aee22f3cb4049c4bccacbacb0fae6
ToppCell356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells)

LAMA4 RYR2 MAMDC2 PDZRN3 SHISA3

8.50e-0517711257617270f49cd6b7ba66db72d20560cee985012b2
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

RGCC AGBL3 MAVS ADAMTS6 RORA

8.73e-05178112531c847d7f7aa0f6d820afbb45d507992f5e9dc2f
ToppCell3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue

PRSS3 HLA-DMA PHETA2 ARHGAP22 ZNF469

9.20e-051801125a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

LAMA4 RYR2 LDB3 DCLK2 PDZRN3

9.20e-051801125d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

LAMA4 RYR2 ABCA6 MAMDC2 PDZRN3

9.44e-0518111259ede19228ba5c0668a9c06c915510b95585216ef
ToppCelldroplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESRP1 TEX15 CHI3L1 TBL2 PLXNB1

9.69e-051821125cfba75c1ffc39ac76db9e8e27394731942882b30
ToppCelldroplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESRP1 TEX15 CHI3L1 TBL2 PLXNB1

9.69e-051821125d836bfdc298ecd3558a973e393a329eb8bd59d79
ToppCelldroplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ESRP1 TEX15 CHI3L1 TBL2 PLXNB1

9.69e-0518211257e7c7a26460d3003cdf0c0ffb96208a566aa09a7
ToppCelldroplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PLB1 VTN ESRP1 CHI3L1 PLXNB1

1.02e-041841125204d16c48f822c98dc4118ac97a4f99f7e1163c8
ToppCelldroplet-Lung-21m-Epithelial-airway_epithelial-club_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PLB1 VTN ESRP1 CHI3L1 PLXNB1

1.02e-0418411259365cdc52a2419e3f27e1c1c9310fa707d1e506b
ToppCelldroplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRSS3 PLB1 VTN ESRP1 PLXNB1

1.02e-0418411257cc3b9bba1f600b40b02fe2456b5d007dbf9fa37
ToppCelldroplet-Lung-nan-21m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRSS3 PLB1 VTN ESRP1 PLXNB1

1.02e-04184112553b71c4ac86dc5e42763b8f64fbc917177531017
ToppCell3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO18A ABCA7 ANKRD52 TLCD3A PLXNB1

1.05e-041851125d42f6722a6771752cd744146a09e2ead9b7252bc
ToppCellPND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass

ABCA3 RGCC TEX15 CHI3L1 ESRP2

1.05e-0418511252b854df79cfe2cb4d2f9c2938a066e0aa3649325
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLB1 STAB1 ARHGAP22 ABCA6 MAMDC2

1.05e-0418511258207f9eff113eed429e961748c6b17d672a13b33
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LAMA4 RYR2 ABCA6 MAMDC2 TNFAIP6

1.07e-0418611255473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARHGAP10 LAMA4 MAB21L2 FRY LDB3

1.07e-0418611250c477016c1b539b3086a8066c3c6443f08c222a3
ToppCelldroplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPL ESRP1 ADAMTS6 TBL2 PLXNB1

1.10e-0418711255fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCelldroplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPL ESRP1 ADAMTS6 TBL2 PLXNB1

1.10e-041871125766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

LAMA4 SEMA6D ADAMTS6 GPR153 RORA

1.10e-04187112513731298bc562ec29582f5da1b4c97261284f6f1
ToppCelldroplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPL ESRP1 ADAMTS6 TBL2 PLXNB1

1.10e-041871125f49d06600060deeb2fc1b1da5b93496535f20104
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue

STAB1 MAMDC2 SLC38A7 WDFY3 TNFAIP6

1.13e-041881125d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue

STAB1 MAMDC2 SLC38A7 WDFY3 TNFAIP6

1.13e-0418811250bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCellMesenchymal_cells-Osteoblasts|World / Lineage and Cell class

PLB1 ZNF469 GPR153 MAMDC2 PLXNB1

1.13e-04188112589f7f5a51be7e046a63e2413f86c521ae4b6718f
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMA4 RYR2 LDB3 MAMDC2

1.19e-0419011252e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCellMesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor

LDB3 SEMA6D ADAMTS6 DCLK2 PDZRN3

1.19e-041901125645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP10 LAMA4 RYR2 LDB3 MAMDC2

1.19e-0419011250028f886c789ba238c031eae5d96acaed4af8c25
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMA4 CHI3L1 RYR2 ABCA6 PDZRN3

1.22e-041911125b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellfacs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RYR2 LDB3 UCP3 OGDHL GNB3

1.22e-041911125543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LAMA4 RYR2 RORA TNFAIP6 PDZRN3

1.22e-04191112508720998aa55131d7377c4c67c4c935865bd7d79
ToppCellfacs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RYR2 LDB3 UCP3 OGDHL GNB3

1.22e-0419111259d7d680da3979e256191b534ebd14c5383e0cf93
Drugnaringenin chalcone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.76e-0951124ctd:C027329
Druganthrarobin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.76e-0951124ctd:C032186
DrugScopoletin

UGT1A10 UGT1A8 UGT1A7 TICAM1 SREBF1 UGT1A9

3.37e-09271126ctd:D012603
Drug1,2,5,8-tetrahydroxy anthraquinone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.26e-0961124ctd:C543211
Drugalloin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.26e-0961124ctd:C006457
Drug2',5'-dihydroxychalcone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.26e-0961124ctd:C107497
Drug2',4'-dihydroxychalcone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.92e-0871124ctd:C059354
DrugC1 11-32

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.14e-08181125CID000443077
DrugC11131

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.14e-08181125CID000443076
Drug1,4-dihydroxyanthraquinone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.83e-0881124ctd:C034890
Drugestriol-16-glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

5.03e-08211125CID000122281
DrugWoodward's reagent K

UGT1A10 UGT1A8 UGT1A7 APEH UGT1A9 SLC4A1

6.51e-08431126CID000077804
DrugAC1MRQNQ

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.86e-0891124CID003522271
DrugDHPASiU

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.86e-0891124CID000197602
Drug3-iodophenol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.86e-0891124CID000012272
DrugAC1L4J7U

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.86e-0891124CID000186631
DrugChebi:32663

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.86e-0891124CID005460873
Drugamidoxime

VTN UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.25e-08231125CID000465967
Drugestradiol-3-glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

8.25e-08231125CID000066651
Drug2,6-dihydroxyanthraquinone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.14e-07101124ctd:C034889
DrugThymol

UGT1A10 UGT1A8 UGT1A7 SREBF1 UGT1A9

1.59e-07261125ctd:D013943
Drugaminopyrine

HLA-DMA UGT1A10 UGT1A8 UGT1A7 APC2 APEH UGT1A9 CYP2W1 UGT2B28

1.74e-071711129CID000006009
Drug4-nitrophenyl)imidazole

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.78e-07111124CID000123155
DrugAC1O5XMV

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.78e-07111124CID006442661
DrugN-OH-DABZ

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.66e-07121124CID000051366
Drug1-O-beta-D-glucopyranosyl-D-mannitol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.66e-07121124CID000088735
Drug4-hydroxyestrone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.66e-07121124ctd:C026418
Drug2,4,6-TCB

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.66e-07121124CID000037247
Drugnonanoyl-N-methylglucamide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.66e-07121124CID000160090
Drug7,7,7-triphenylheptanoic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.66e-07121124CID000276709
Drug7-hydroxycoumarin glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.85e-07291125CID000125641
Drug2-hydroxyestrone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.83e-07131124ctd:C024980
Drugtritanol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.83e-07131124CID000006457
Drug5-azido-UDP-glucuronic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.83e-07131124CID003081279
Drugcotinine-N-glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.83e-07131124CID000000411
Drugalizarin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.83e-07131124ctd:C010078
DrugPCB 156

HLA-DMA UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.04e-07311125CID000038019
Drug4-ethylphenol

UGT1A10 UGT1A8 UGT1A7 APEH UGT1A9

4.04e-07311125CID000031242
Druguridine 5'-diphosphoglucuronic acid

UGT1A10 UGT1A8 UGT1A7 GART UGT1A9 CYP2W1 CHPF2 UGT2B28 GMPPB

4.07e-071891129CID000000390
Drughydratropic acid

UGT1A10 UGT1A8 UGT1A7

4.62e-0741123ctd:C013025
Drug2-vanillin

UGT1A10 UGT1A8 UGT1A7

4.62e-0741123ctd:C060843
Drugdiphenylacetic acid

UGT1A10 UGT1A8 UGT1A7

4.62e-0741123ctd:C037760
Drugpropranolol glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.35e-07141124CID000119515
DrugPCB-61

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.35e-07141124CID000036401
DrugAC1Q6OQG

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

5.60e-07331125CID000009686
DrugBP-3,6-quinol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

5.60e-07331125CID000119292
Drug2,2',3,5,5'-pentachlorobiphenyl

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.26e-07151124CID000040469
Drugafloqualone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.26e-07151124CID000002040
Drugnaphthyl sulphate

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.26e-07151124CID000114775
Drugcoumarin-3-carboxylic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.26e-07151124CID000010752
Drugbergamottin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.26e-07151124ctd:C068337
Drugsulforaphane nitrile

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.26e-07151124CID000543743
DrugAC1NOWCJ

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

7.60e-07351125CID005120112
Drug3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

7.60e-07351125CID010436171
Drugestrone-3-glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

7.60e-07351125CID000115255
Drugquercetin-3,4'-diglucoside

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.65e-07161124CID005320835
Drug1'-hydroxyestragole

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.65e-07161124CID000040003
Drugbilirubin-phosphate

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.65e-07161124CID005497144
Drugl-borneol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.01e-06371125CID000010049
Drugisovaleric acid

UGT1A10 UGT1A8 UGT1A7

1.15e-0651123ctd:C008216
Drugbiphenylylacetic acid

UGT1A10 UGT1A8 UGT1A7

1.15e-0651123ctd:C012776
Drugformononetin

UGT1A10 UGT1A8 UGT1A7 UGT1A9 RORA

1.16e-06381125ctd:C007768
Drug3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.26e-06171124CID000003573
Drug6-hydroxychrysene

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.26e-06171124CID000037766
Drug1-phenylimidazole

UGT1A10 UGT1A8 UGT1A7 APEH UGT1A9

1.33e-06391125CID000081595
Drugharmol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.51e-06401125CID000068094
DrugSureCN12722713

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.61e-06181124CID005488034
Drugethyl-beta-D-6-glucosiduronic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.61e-06181124CID000152226
DrugBr 2

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.61e-06181124CID003060900
Drug2,3,7-trichlorodibenzo-p-dioxin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.61e-06181124CID000036614
DrugApApG

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.61e-06181124CID003081975
Drugtestosterone glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

1.71e-06411125CID000108192
Drug5-hydroxytryptophol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 ASMT

1.94e-06421125CID000009061
Drug9-OH-risperidone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.03e-06191124CID000475100
Drug5alpha-spirostan-3beta-ol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.03e-06191124CID000091433
Drugalmokalant

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.03e-06191124CID003033962
Drugglucosiduronate

ABCA3 UGT1A10 UGT1A8 UGT1A7 UGT1A9 CHPF2 UGT2B28 GMPPB

2.10e-061711128CID000000610
Drugandrosterone glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.18e-06431125CID000114833
Drug7,8-benzoquinoline

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.18e-06431125CID000009191
Drug3-phenylpropionic acid

UGT1A10 UGT1A8 UGT1A7

2.29e-0661123ctd:C035253
DrugIndoprofen

UGT1A10 UGT1A8 UGT1A7

2.29e-0661123ctd:D007216
DrugAC1N8H7N

ABCA3 UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.38e-06781126CID004318740
DrugMS-222

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

2.45e-06441125CID000011400
Drugtectochrysin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.53e-06201124CID005281954
DrugAC1L1OBF

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.53e-06201124CID000032736
Drug4'-hydroxydiclofenac

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.53e-06201124CID000116545
Drugentacapone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.53e-06201124ctd:C071192
Drugdulcin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.11e-06211124CID000009013
DrugBenzamidoxime hydrochloride

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.11e-06211124CID000069186
Drugamonafide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.79e-06221124CID000050515
DrugN-methylpiperazine

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.79e-06221124CID000053167
Drugplumbagin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.79e-06221124ctd:C014758
Drugsalicylamide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

3.81e-06481125CID000005147
Drugcampestrol

UGT1A10 UGT1A8 UGT1A7 SREBF1 UGT1A9

4.22e-06491125CID000010134
Drugphenanthridine

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.57e-06231124CID000009189
DrugAS-3201

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.46e-06241124CID000153948
DrugAC1NQGK1

UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT2B28

5.69e-06521125CID005195977
Drug(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A

ABCA3 ARHGAP10 LAMA4 RYR2 DLK2 SLC38A7 REPS2 PLXNB1

6.01e-0619711286663_DN
DrugDEPC

UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC4A1

6.26e-06531125CID000015357
Drugglabridin

UGT1A10 UGT1A8 UGT1A9

6.37e-0681123ctd:C107601
DiseaseN-acetyl-4-chlorophenylalanine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.11e-1051104EFO_0801060
Disease5-hydroxyindole sulfate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.11e-1051104EFO_0800085
Diseasenuclear receptor subfamily 1 group D member 2 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.11e-1051104EFO_0801853
DiseaseX-21339 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.34e-0971104EFO_0800808
DiseaseX-11793--oxidized bilirubin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0021260
DiseaseSuccinimide measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0022118
DiseaseX-11530 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0021249
Diseasesulfate of piperine metabolite C16H19NO3 (2) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0801034
Diseasecholelithiasis, bilirubin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0004570, EFO_0004799
DiseaseX-11522 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0800696
DiseaseX-10458 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0800692
DiseaseX-24849 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0800909
Diseaseserum N-desmethylclozapine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0600043
Diseaseplasma clozapine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0600038
Diseasemembrane-associated progesterone receptor component 1 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0802740
DiseaseX-16946 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-0881104EFO_0800766
DiseaseX-11442 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0021236
DiseaseX-11441 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0021235
Diseasecirculating cell free DNA measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0004739
Diseasesulfate of piperine metabolite C18H21NO3 (3) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0801037
Diseasesulfate of piperine metabolite C18H21NO3 (1) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0801036
DiseaseX-11880 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0800698
Diseaseprotein-tyrosine kinase 6 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0020691
Diseasetestis-specific chromodomain protein Y 1 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0802127
Diseasebilirubin measurement, response to xenobiotic stimulus

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-0891104EFO_0004570, GO_0009410
Diseasebilirubin measurement, response to tenofovir

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.77e-08101104EFO_0004570, EFO_0009279
DiseaseX-21448 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.77e-08101104EFO_0800816
DiseaseUDP-glucuronosyltransferase 1-6 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.77e-08101104EFO_0802185
DiseaseX-23974 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.77e-08101104EFO_0800867
Diseaseindole-3-carboxylate measurement

UGT1A10 UGT1A8 UGT1A9

5.04e-0831103EFO_0800043
Diseaseblood 4-oxo-retinoic acid measurement

UGT1A10 UGT1A8 UGT1A9

5.04e-0831103EFO_0022216
Diseasepregnenetriol sulfate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.91e-08111104EFO_0800586
Diseaseplasma N-desmethylclozapine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.91e-08111104EFO_0600039
Diseasehistidine betaine (hercynine) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.91e-08111104EFO_0800972
DiseaseX-21796 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.91e-08111104EFO_0800825
Diseaseinsomnia, bilirubin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.91e-08111104EFO_0004570, EFO_0004698
Diseasealdosterone measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.91e-08111104EFO_0010219
Diseasep-cresol glucuronide measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.84e-08121104EFO_0800079
Diseasebiliverdin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.84e-08121104EFO_0021033
Diseasepregnenetriol disulfate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-07131104EFO_0800587
Diseaseretinol dehydrogenase 16 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-07131104EFO_0802007
Diseaselow density lipoprotein cholesterol measurement, body fat percentage

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.19e-07171104EFO_0004611, EFO_0007800
DiseaseX-21441 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.19e-07171104EFO_0800814
Diseaseangiopoietin-related protein 1 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.37e-07181104EFO_0801382
Disease3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement

UGT1A10 UGT1A8 UGT1A9

1.00e-0661103EFO_0800566
Diseasetissue factor measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.04e-06211104EFO_0010623
Diseaseneuroblastoma, cutaneous melanoma

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.49e-06281104EFO_0000389, EFO_0000621
Diseasexanthurenate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.04e-06291104EFO_0010551
Diseaseresponse to dolutegravir

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.65e-06301104EFO_0600017
Diseaseindoleacetate measurement

UGT1A10 UGT1A8 UGT1A9

5.93e-06101103EFO_0021015
Diseasevitamin D deficiency

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.10e-05371104EFO_0003762
DiseaseX-24588 measurement

UGT1A10 UGT1A8 UGT1A9

1.40e-05131103EFO_0800898
Diseasethyroxine measurement

UGT1A10 UGT1A8 UGT1A7 LAMA4 UGT1A9

1.51e-05831105EFO_0005130
Diseasehormone measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9 RYR2

1.60e-05841105EFO_0004730
Diseasetype 2 diabetes mellitus (biomarker_via_orthology)

UGT1A10 UGT1A8 UGT1A7 SREBF1 UGT1A9 CAPN10

1.93e-051471106DOID:9352 (biomarker_via_orthology)
Diseasevitamin D measurement, COVID-19

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.40e-05491104EFO_0004631, MONDO_0100096
Diseaseserum gamma-glutamyl transferase measurement

PLB1 ARHGAP10 UGT1A10 UGT1A8 UGT1A7 UGT1A9 RYR2 CYP2W1 STAB1 SEMA6D PCIF1 RORA TBL2

3.69e-0591411013EFO_0004532
Diseaseurate measurement, spine bone mineral density

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.64e-05581104EFO_0004531, EFO_0007701
Diseasenon-high density lipoprotein cholesterol measurement

VTN UGT1A10 UGT1A8 UGT1A7 PEX6 UGT1A9 DENND4C ABCA6 PCIF1 HYDIN VDAC2

7.41e-0571311011EFO_0005689
DiseaseARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2

RYR2 LDB3

1.37e-0451102C1832931
Diseaseapolipoprotein B measurement

VTN PSD UGT1A10 UGT1A8 UGT1A7 PEX6 UGT1A9 ABCA6 PCIF1 HYDIN

1.91e-0466311010EFO_0004615
Diseasemetabolite measurement

UGT1A10 UGT1A8 UGT1A7 SREBF1 UGT1A9 STAB1 ARHGAP22 PCIF1 VDAC2

2.55e-045601109EFO_0004725
DiseaseAbnormality of the eye

APC2 MAB21L1

2.86e-0471102C4316870
Diseasecholelithiasis

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.35e-04881104EFO_0004799
Diseasetriglycerides to total lipids in large VLDL percentage

CYP2W1 ABCA6 PCIF1

4.18e-04391103EFO_0022332
Diseasecholesterol in very small VLDL measurement

CYP2W1 ABCA6 PCIF1

4.50e-04401103EFO_0022231
Diseasefree androgen index

ARHGAP10 UGT1A10 UGT1A8 UGT1A7 UGT1A9 ZNF469 VDAC2

5.17e-043741107EFO_0007005
Diseasefree cholesterol in very small VLDL measurement

CYP2W1 ABCA6 PCIF1

7.25e-04471103EFO_0022275
Diseasegallstones

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.27e-041081104EFO_0004210
Diseasedodecanedioate measurement

UGT1A10 UGT1A8

8.87e-04121102EFO_0021054
Diseasephospholipids in IDL measurement

CYP2W1 ABCA6 PCIF1

9.75e-04521103EFO_0022164
Diseasetriglycerides to total lipids in very large VLDL percentage

CYP2W1 ABCA6 PCIF1

1.03e-03531103EFO_0022340
Diseasesalicylurate measurement

LMF1 RYR2

1.05e-03131102EFO_0010532
Diseasecholesteryl esters to total lipids in large VLDL percentage

CYP2W1 ABCA6 PCIF1

1.21e-03561103EFO_0022250
DiseaseHamman-Rich syndrome

ABCA3 RTEL1

1.22e-03141102C0085786
Diseasecentral nervous system cancer, glioblastoma multiforme

LMF1 RTEL1

1.22e-03141102EFO_0000326, EFO_0000519
Diseasefree cholesterol to total lipids in medium VLDL percentage

CYP2W1 ABCA6 PCIF1

1.27e-03571103EFO_0022284
Diseaseapolipoprotein A 1 measurement

VTN PEX6 CYP2W1 AGBL3 STAB1 LDB3 ABCA6 PCIF1 RORA DLEC1

1.29e-0384811010EFO_0004614
Diseasebilirubin measurement

UGT1A10 UGT1A8 UGT1A7 PEX6 UGT1A9 SIK2 RORA

1.37e-034421107EFO_0004570
DiseaseYKL40 measurement

CHI3L1 RORA

1.40e-03151102EFO_0004869
Diseasehematocrit

RTEL1 ARHGAP10 SREBF1 PEX6 SLC4A1 AGBL3 STAB1 ABCA6 RORA ANKRD52 HYDIN

1.41e-03101111011EFO_0004348
Diseasefree cholesterol to total lipids in very large VLDL percentage

CYP2W1 ABCA6 PCIF1

1.41e-03591103EFO_0022289
Diseasephospholipids:total lipids ratio

VTN PSD CYP2W1 ABCA6 PCIF1

1.64e-032271105EFO_0020946
Diseasevitamin D measurement

PLB1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 VDAC2

1.66e-033361106EFO_0004631
Diseaseattention deficit hyperactivity disorder

XRN2 UGT1A10 UGT1A8 UGT1A9 SEMA6D DLEC1

2.15e-033541106EFO_0003888
Diseaseurate measurement, bone density

PLB1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 DNAH14 ARHGAP22 CTNNA1

2.26e-036191108EFO_0003923, EFO_0004531
Diseaseneck circumference

ANKRD52 PDZRN3

2.26e-03191102EFO_0011043
Diseasecorneal hysteresis

ZNF469 ABCA6

2.50e-03201102EFO_0010066
DiseaseIdiopathic Pulmonary Fibrosis

ABCA3 RTEL1

2.76e-03211102C1800706
Diseaseglioma

LMF1 RTEL1

3.03e-03221102EFO_0005543

Protein segments in the cluster

PeptideGeneStartEntry
RCALLTADSFGDPFF

AGBL3

36

Q8NEM8
GPLLVFEEAFFSFCE

SLC4A1

466

P02730
EAAPESLVVFSACFG

ADAM21

116

Q9UKJ8
LCDFGFARTLAAPGD

CDKL3

141

Q8IVW4
FPDLFSDLDKCSDQG

ABCA6

756

Q8N139
PEANFELSATDFLVC

ABCA6

1186

Q8N139
DPEGLFAEANAVACT

CYP2W1

276

Q8TAV3
DLLSPVNVDDDFCFG

ABCA3

436

Q99758
DAAFPAADSSLFCDL

CAPN10

16

Q9HC96
FAACELGVFDLLAEA

ASMT

26

P46597
FCLEFLLDNGADPSL

ANKRD52

531

Q8NB46
SACDDFERALQGPLF

ARRDC3

366

Q96B67
CDAIEGFFNDSLPRG

ADAMTS6

716

Q9UKP5
AFGFGCESLALLEEQ

ABCA7

696

Q8IZY2
DGRPTGDAFVLFACE

ESRP1

366

Q6NXG1
ADCLPCVFLVDFEFG

RAG2

176

P55895
GDLPFSNESFISADC

PDZRN3

616

Q9UPQ7
AGALDLPAGSCAFEE

MAMDC2

16

Q7Z304
PEEGFLLGCVFAIAD

PAXIP1

601

Q6ZW49
FCFDIEAADRPGVSL

ARHGAP10

336

A1A4S6
SQVDSPFSGCFEDLA

MAVS

426

Q7Z434
GCDFPVEAGDKFIEA

LDB3

671

O75112
GASEEAPVFLLFLDC

MTMR11

426

A4FU01
VEAATDLFLCPFLGS

LRIG3

911

Q6UXM1
TTEAFFCLDNVGDLP

CFAP65

261

Q6ZU64
LAFEGEAACRAFLEP

LENG8

761

Q96PV6
DLFSVTFDLGFCSPD

FANCM

1226

Q8IYD8
ADPFFVLNSDVICDF

GMPPB

101

Q9Y5P6
GDDDVFIACGPEKFR

DCLK2

261

Q8N568
ISPFVCLSGNFDDDL

DDX60

1586

Q8IY21
EGDGSCFPDALDRFL

CHI3L1

36

P36222
SGASALCAFPLDEVD

PLXNB1

316

O43157
IFCQFDPKLEAADEG

OGDHL

316

Q9ULD0
AFVVDLLFCGPNELD

OR4F6

161

Q8NGB9
LLFCGPNELDSFFCD

OR4F6

166

Q8NGB9
ELCAAGFPLLAEDFG

PEX6

666

Q13608
DAFALTAFECEPQAL

GPR153

501

Q6NV75
AVSPDFNLFISGACD

GNB3

191

P16520
SPEAFFVLNADVCSD

GMPPA

106

Q96IJ6
GCFDDDDAPSSLAAA

APC2

776

O95996
ELPDCTLAHFALGAD

CMPK2

36

Q5EBM0
EPSDIAACFREAGFG

CENPB

376

P07199
FSPLDIGDFESNLFC

HYDIN

3911

Q4G0P3
RLALVDPEGFQADFC

BICRAL

811

Q6AI39
SGAAAGDFCLLELEP

DSCC1

36

Q9BVC3
LSGSFEANPPFCEEL

PCIF1

546

Q9H4Z3
AAAGEFADDPCSSVK

CTNNA1

106

P35221
EDFTCLPLFLANGAE

CENPL

176

Q8N0S6
EQGDAPAILFDKEFC

HLA-DMA

91

P28067
GLAFFDDCIEKLFPD

DENND4C

641

Q5VZ89
DGAFDLAAGRFLCTV

C1QTNF8

146

P60827
VCSFSFALNDGVPDV

DNAH14

2986

Q0VDD8
FNFVDDGSLPGCAVL

MAB21L2

86

Q9Y586
SAILAAFQPAACDDA

FRY

2666

Q5TBA9
PEGFAGRFCTINLDD

DLK2

201

Q6UY11
CLQRGTLFEDADFPA

CAPN9

36

O14815
QFFPDCLGDFDDFIL

DLEC1

441

Q9Y238
GECLAAFAGAFPVAF

RYR2

3156

Q92736
CSRAASGDDNAFPFD

LAMA4

21

Q16363
ELADLFCDSPLASSF

FAM167A

176

Q96KS9
DTLGAFADSPLGCDL

FOXN4

446

Q96NZ1
DDFAALAACLGPLFA

RTEL1

926

Q9NZ71
AFFMASGPCLDDIAE

RTN4IP1

341

Q8WWV3
ADGPDSFSCVFEAIL

PSD

396

A5PKW4
AACFTLAPSEGAFEE

TIMM29

71

Q9BSF4
FNFVDDGSLPGCAVL

MAB21L1

86

Q13394
SCLDEPATEFFGNTA

NIN

1106

Q8N4C6
VEAFSFPASGCQAEA

SIK2

396

Q9H0K1
GFQCPEDFDTLDATI

SHISA3

41

A0PJX4
ICGFLTFGAAVDPDV

SLC38A7

296

Q9NVC3
FALECSPAFQVSDDE

SGO2

1176

Q562F6
EQSFLDDFIACVPGS

MYCBP2

2236

O75592
AEFCPALVSELLDFF

SCGB1D2

21

O95969
PTGDAFALFACEELA

ESRP2

401

Q9H6T0
LADGLPDTSFFAPDC

PLB1

986

Q6P1J6
FFCDSGPLLALACAD

OR6J1

176

Q8NGC5
SDFEDCLTLFAGDPG

STRC

1486

Q7RTU9
LQDSFDCGEKPLFDS

ARHGAP22

206

Q7Z5H3
SFGFGLEPREADCVF

ROBO4

916

Q8WZ75
FSEAALEQALGEPCD

SREBF1

6

P36956
VEAGFPFSSDCLPDL

APEH

631

P13798
LVAEAAAAPAFLEAF

CHPF2

496

Q9P2E5
GTAACFADLVTFPLD

UCP3

21

P55916
VPEEFAFAICFDAPG

PHETA2

81

Q6ICB4
SFLDFDLEDDPGCLA

TNFAIP6

176

P98066
SFPDCAAGFLTAAAD

ZBTB45

236

Q96K62
SFDAVFLDPFDTCGL

UGT1A10

141

Q9HAW8
VEFDTSLEGFGCLFL

WDFY3

1046

Q8IZQ1
LSDADCDGALTLPEF

REPS2

326

Q8NFH8
ASPDVFKSLGCEDFI

RORA

386

P35398
LEALGVPDGATFCED

TICAM1

416

Q8IUC6
ALCEFDAVLADFASP

RGCC

31

Q9H4X1
DCKFGLTFQSPAEAD

SPRED3

86

Q2MJR0
DLGDFFVGCIFTAEL

TLCD3A

141

Q8TBR7
ADSLPCAEGEFIFLR

XRN2

291

Q9H0D6
LGCDVDFDFAGPAIH

VDAC2

136

P45880
VFGSDTFCEPFDDSL

STAB1

2541

Q9NY15
SFDAVFLDPFDNCGL

UGT1A9

141

O60656
EEACSFILSADFPAL

GART

131

P22102
DCLAAFFAADELKGD

USP20

541

Q9Y2K6
LGAEGAFQCLEETPF

ZNF469

676

Q96JG9
DADGCEALGTVAVPF

PRSS3

61

P35030
PGEFSCIAEEQAFLS

ZNF212

231

Q9UDV6
PFTCGVNFGDSLEDL

TEX15

1811

Q9BXT5
DIIFADAFFPCGELL

UGT2B28

146

Q9BY64
DGEEISGLARCPFDA

SEMA6D

156

Q8NFY4
AEEELCSGKPFDAFT

VTN

151

P04004
SPFREQSFLCAAGDA

MYO18A

6

O95411
FEEAAGAAPCRLALS

TBL2

326

Q9Y4P3
CFDAVFLDPFDACGL

UGT1A7

141

Q9HAW7
EAFAATFCIVGFPDL

TSR3

166

Q9UJK0
SFDAVFLDPFDACGL

UGT1A8

141

Q9HAW9
LGTEEFFDPTADASC

VPS13D

471

Q5THJ4
ACFDDATLGFLFPSG

LMF1

321

Q96S06